Sangamo Therapeutics Inc (NASDAQ: SGMO) kicked off on Tuesday, down -6.14% from the previous trading day, before settling in for the closing price of $0.63. Over the past 52 weeks, SGMO has traded in a range of $0.41-$3.18.
Healthcare Sector giant saw their annual sales surged by 10.57% over the last five years. While this was happening, its average annual earnings per share was recorded 40.56%. With a float of $291.31 million, this company’s outstanding shares have now reached $301.71 million.
Sangamo Therapeutics Inc (SGMO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Sangamo Therapeutics Inc is 3.44%, while institutional ownership is 17.29%.
Sangamo Therapeutics Inc (SGMO) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported 0.04 earnings per share (EPS), higher than consensus estimate (set at -0.04) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.56% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.07% during the next five years compared to 10.57% growth over the previous five years of trading.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators
Take a look at Sangamo Therapeutics Inc’s (SGMO) current performance indicators. Last quarter, stock had a quick ratio of 1.05. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.00 in the next quarter and is forecasted to reach -0.29 in one year’s time.
Technical Analysis of Sangamo Therapeutics Inc (SGMO)
Analysing the last 5-days average volume posted by the [Sangamo Therapeutics Inc, SGMO], we can find that recorded value of 4.15 million was lower than the volume posted last year of 5.83 million. As of the previous 9 days, the stock’s Stochastic %D was 14.70%.
During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 50.42%, which indicates a significant increase from 4.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0553 in the past 14 days, which was higher than the 0.0462 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6007, while its 200-day Moving Average is $0.7034. Now, the first resistance to watch is $0.6185. This is followed by the second major resistance level at $0.6466. The third major resistance level sits at $0.6648. If the price goes on to break the first support level at $0.5722, it is likely to go to the next support level at $0.5540. Now, if the price goes above the second support level, the third support stands at $0.5259.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats
The company with the Market Capitalisation of 178.16 million has total of 301,709K Shares Outstanding. Its annual sales at the moment are 57,800 K in contrast with the sum of -97,940 K annual income. Company’s last quarter sales were recorded 18,310 K and last quarter income was -19,990 K.
